Dr. Gary Gilkeson of the Medical University of South Carolina discusses his Lupus Foundation of America funded study on the potential use of human mesenchymal stem cells as a therapy for lupus.
New Research Gives Insight for Improving Future Lupus Clinical Trials
In 2009, the Lupus Foundation of America established the LFA Collective Data Analysis Initiative (LFA CDAI), a first-in-lupus collaboration among multiple companies with a shared goal -- to improve our collective ability to get new treatments to people with lupus. In this podcast,Dr. Kenneth Kalunian, associate director of the Center for Innovative Therapy (CIT) at the University of California San Diego,and Chair of the LFA-CDAI, discusses a data analysis that was presented during the 2013 American College of Rheumatology Annual Scientific Meeting.
Presenter: Kenneth C. Kalunian, MD, associate director of the Center for Innovative Therapy (CIT) at the University of California San Diego.
Presentation Date: October 28, 2013
Length: Six minutes
Study examines the effects of the antimalarial drug, hydroxycloroquine, on antiphospholipid antibodies that are responsible for pregnancy complications in women with lupus and antiphospholipid syndrome.